Jinling Pharmaceutical Co Ltd banner
J

Jinling Pharmaceutical Co Ltd
SZSE:000919

Watchlist Manager
Jinling Pharmaceutical Co Ltd
SZSE:000919
Watchlist
Price: 7.43 CNY 3.48% Market Closed
Market Cap: ¥4.6B

Relative Value

The Relative Value of one Jinling Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 7.43 CNY, Jinling Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Jinling Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Jinling Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jinling Pharmaceutical Co Ltd
SZSE:000919
4.6B CNY 1.3 123.2 -100.8 -100.8
US
Eli Lilly and Co
NYSE:LLY
932.9B USD 14.3 45.2 30.5 32.5
US
Johnson & Johnson
NYSE:JNJ
578.6B USD 6.1 21.6 15 18.4
CH
Roche Holding AG
SIX:ROG
259B CHF 4.2 20.1 11.9 13.4
CH
Novartis AG
SIX:NOVN
236B CHF 5.4 21.8 13.5 17.3
UK
AstraZeneca PLC
LSE:AZN
219.1B GBP 5 28.7 15.9 22.4
US
Merck & Co Inc
NYSE:MRK
287.1B USD 4.4 15.7 9.8 11.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 11 8.1 9.5
US
Pfizer Inc
NYSE:PFE
153.8B USD 2.5 19.8 7.6 10.2
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD 2.5 17.2 7.2 8.9
P/E Multiple
Earnings Growth PEG
CN
J
Jinling Pharmaceutical Co Ltd
SZSE:000919
Average P/E: 32.4
123.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
45.2
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.6
7%
3.1
CH
Roche Holding AG
SIX:ROG
20.1
14%
1.4
CH
Novartis AG
SIX:NOVN
21.8
14%
1.6
UK
AstraZeneca PLC
LSE:AZN
28.7
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
US
Pfizer Inc
NYSE:PFE
19.8
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.2
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
J
Jinling Pharmaceutical Co Ltd
SZSE:000919
Average EV/EBITDA: 46.4
Negative Multiple: -100.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
30.5
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15
2%
7.5
CH
Roche Holding AG
SIX:ROG
11.9
6%
2
CH
Novartis AG
SIX:NOVN
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
15.9
13%
1.2
US
Merck & Co Inc
NYSE:MRK
9.8
3%
3.3
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.1
1%
8.1
US
Pfizer Inc
NYSE:PFE
7.6
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
J
Jinling Pharmaceutical Co Ltd
SZSE:000919
Average EV/EBIT: 101
Negative Multiple: -100.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.5
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
18.4
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
CH
Novartis AG
SIX:NOVN
17.3
9%
1.9
UK
AstraZeneca PLC
LSE:AZN
22.4
21%
1.1
US
Merck & Co Inc
NYSE:MRK
11.9
6%
2
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
3%
3.2
US
Pfizer Inc
NYSE:PFE
10.2
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.9
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett